Colleen Tracy James and Andrew Cochran Speak at the LABEST Week 2026

Thursday, May 21, 2026

Cahill partners Colleen Tracy James and Andrew Cochran will participate in the “Early Stage Drug Development and IP” at the LABEST Week 2026 on May 21.

Colleen will serve as moderator of the discussion, with Andrew speaking on the panel. They will be joined by esteemed panelists, including Jason Lott, Regional Director of the U.S. Patent & Trademark Office, who will together explore the intellectual property and strategic considerations for start-ups from discovery and early-stage funding through preclinical development and commercialization.

LABEST Week brings together life sciences innovators, investors, and advisors to explore key trends and opportunities in biotech and early-stage drug development.

To learn more about the event and register, click here